Evidence map›Paper›PMID 9528773›Full record

ArticleMolecular and cellular biology1998

Activation of Src family members is not required for the platelet-derived growth factor beta receptor to initiate mitogenesis.

K A DeMali, A Kazlauskas

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

K A DeMaliSchepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts 02114, USA.
A Kazlauskas
Harvard University · USMassachusetts Eye and Ear Infirmary · US

Funding

PDGF RECEPTOR-ASSOCIATED PROTEINS IN SIGNALINGR01GM048339 · NIGMS · SCHEPENS EYE RESEARCH INSTITUTE · PI KAZLAUSKAS, ANDRIUS · 1992 to 2003
$1.2M
ACTIVATION OF RTK KINASE ACTIVITYR01EY011693 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI KAZLAUSKAS, ANDRIUS · 1996 to 1999
–
NEI NIH HHS EY11693NIGMS NIH HHS GM48339
6 · The paper itself

Abstract

The basal activity of Src family kinases is readily detectable throughout the cell cycle and increases by two- to fivefold upon acute stimulation of cells with growth factors such as platelet-derived growth factor. Previous reports have demonstrated a requirement for Src activity for the G1/S and G2/M transitions. With a chimeric alpha-beta PDGF receptor (PDGFR) expressed in fibroblasts, we have investigated the importance of the PDGF-mediated increase in Src activity at the G0/G1 transition for subsequent cell cycle events. A mutant PDGFR chimera that was not able to detectably associate with or activate Src was compromised in its ability to mediate tyrosine phosphorylation of receptor-associated signaling molecules and initiated a submaximal activation of Erk. In contrast to these early cell cycle events, later responses such as entry of cells into S phase and cell proliferation proceeded normally when Src activity did not increase following acute stimulation with PDGF. We conclude that the initial burst of Src activity is required for efficient tyrosine phosphorylation of receptor-associated proteins such as PLCgamma, RasGAP, Shc, and SHP-2 and for maximal activation of Erk. Surprisingly, these events are not required for PDGF-dependent cell proliferation. Finally, later cell cycle events do not require that Src be activated at the G0/G1 transition and leave open the possibility that events such as the G1/S transition require the basal Src activity and/or activation of Src at later times in G1.

Indexed as

MitosisAmino Acid SubstitutionAnimalsCell DivisionCell LineDNA ReplicationEnzyme ActivationG1 PhaseMiceMutagenesis, Site-DirectedReceptor, Platelet-Derived Growth Factor betaReceptors, Platelet-Derived Growth FactorRecombinant Fusion ProteinsResting Phase, Cell Cyclesrc-Family KinasesReceptor, Platelet-Derived Growth Factor betaReceptors, Platelet-Derived Growth FactorRecombinant Fusion Proteinssrc-Family Kinases

Identifiers

PMID9528773
PMCPMC121431
OpenAlexW2137482465

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.